John Hsu

1.9k total citations
59 papers, 1.5k citations indexed

About

John Hsu is a scholar working on General Health Professions, Epidemiology and Molecular Biology. According to data from OpenAlex, John Hsu has authored 59 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in General Health Professions, 14 papers in Epidemiology and 13 papers in Molecular Biology. Recurrent topics in John Hsu's work include Healthcare Policy and Management (9 papers), Influenza Virus Research Studies (7 papers) and Patient-Provider Communication in Healthcare (7 papers). John Hsu is often cited by papers focused on Healthcare Policy and Management (9 papers), Influenza Virus Research Studies (7 papers) and Patient-Provider Communication in Healthcare (7 papers). John Hsu collaborates with scholars based in United States, Taiwan and United Kingdom. John Hsu's co-authors include Hsing‐Pang Hsieh, Vicki Fung, Richard M. Frankel, Richard Brand, Mary Reed, Jie Huang, Joseph P. Newhouse, Joseph V. Selby, Holly Jimison and Chun-Wei Chang and has published in prestigious journals such as JAMA, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

John Hsu

58 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Hsu United States 21 407 335 301 218 217 59 1.5k
Tsegahun Manyazewal Ethiopia 19 337 0.8× 377 1.1× 302 1.0× 137 0.6× 78 0.4× 86 2.0k
Jennifer Williams United States 23 188 0.5× 363 1.1× 479 1.6× 111 0.5× 28 0.1× 63 2.0k
Jon E. Rohde United States 20 505 1.2× 146 0.4× 275 0.9× 67 0.3× 140 0.6× 71 1.7k
Leena Gupta Australia 21 214 0.5× 178 0.5× 221 0.7× 352 1.6× 47 0.2× 74 1.3k
Bin Zou China 19 93 0.2× 415 1.2× 199 0.7× 431 2.0× 55 0.3× 55 1.8k
Mohan Nadkarni United States 13 242 0.6× 104 0.3× 155 0.5× 22 0.1× 125 0.6× 26 1.1k
George E. Wright United States 34 221 0.5× 1.4k 4.3× 589 2.0× 557 2.6× 247 1.1× 147 3.4k
Bernhards Ogutu Kenya 32 259 0.6× 244 0.7× 290 1.0× 48 0.2× 133 0.6× 146 3.3k
Sherri O. Stuver United States 34 248 0.6× 260 0.8× 972 3.2× 54 0.2× 43 0.2× 114 3.3k
Malcolm A Moore Japan 35 283 0.7× 1.2k 3.5× 682 2.3× 72 0.3× 78 0.4× 196 4.3k

Countries citing papers authored by John Hsu

Since Specialization
Citations

This map shows the geographic impact of John Hsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Hsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Hsu more than expected).

Fields of papers citing papers by John Hsu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Hsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Hsu. The network helps show where John Hsu may publish in the future.

Co-authorship network of co-authors of John Hsu

This figure shows the co-authorship network connecting the top 25 collaborators of John Hsu. A scholar is included among the top collaborators of John Hsu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Hsu. John Hsu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hsu, John, Nelly H. Y. Ng, Ju Lynn Ong, et al.. (2025). Evaluating the role of clinical decision support systems in medication safety for older people: a systematic review. Age and Ageing. 54(7). 1 indexed citations
2.
Haimovich, Julian S., Jinghan Cui, Robert W. Yeh, et al.. (2021). Expansion of Insurance Under the Affordable Care Act and Invasive Management of Acute Myocardial Infarction. Cardiovascular revascularization medicine. 39. 90–96. 1 indexed citations
3.
Lin, Shu‐Yu, Mohane Selvaraj Coumar, Fu‐Ming Kuo, et al.. (2020). Drug-like property optimization: Discovery of orally bioavailable quinazoline-based multi-targeted kinase inhibitors. Bioorganic Chemistry. 98. 103689–103689. 9 indexed citations
4.
Hsu, Kai‐Cheng, Wei‐Chun HuangFu, Tzu-Ying Sung, et al.. (2017). Identification of neuraminidase inhibitors against dual H274Y/I222R mutant strains. Scientific Reports. 7(1). 12336–12336. 12 indexed citations
5.
Vogeli, Christine, Richard Brand, John Hsu, et al.. (2016). Implementing a hybrid approach to select patients for care management: variations across practices.. PubMed. 22(5). 358–65. 11 indexed citations
6.
Lin, Wen‐Hsing, Yi-Yu Ke, Chun-Hwa Chen, et al.. (2016). Discovery of novel inhibitors of Aurora kinases with indazole scaffold: In silico fragment-based and knowledge-based drug design. European Journal of Medicinal Chemistry. 124. 186–199. 19 indexed citations
7.
Liu, Chia‐Lin, et al.. (2016). Using mutagenesis to explore conserved residues in the RNA-binding groove of influenza A virus nucleoprotein for antiviral drug development. Scientific Reports. 6(1). 21662–21662. 26 indexed citations
8.
Ke, Yi-Yu, Mohane Selvaraj Coumar, Hui-Yi Shiao, et al.. (2014). Ligand efficiency based approach for efficient virtual screening of compound libraries. European Journal of Medicinal Chemistry. 83. 226–235. 14 indexed citations
9.
Hsu, Kai‐Cheng, Jim‐Tong Horng, Mingyu Fang, et al.. (2013). Parallel Screening of Wild-Type and Drug-Resistant Targets for Anti-Resistance Neuraminidase Inhibitors. PLoS ONE. 8(2). e56704–e56704. 10 indexed citations
10.
Lin, Wen‐Hsing, John Hsu, Chiung‐Tong Chen, et al.. (2013). Discovery of 3-phenyl-1H-5-pyrazolylamine derivatives containing a urea pharmacophore as potent and efficacious inhibitors of FMS-like tyrosine kinase-3 (FLT3). Bioorganic & Medicinal Chemistry. 21(11). 2856–2867. 14 indexed citations
11.
Lin, Wen‐Hsing, Shih-Chieh Yen, Chiung‐Tong Chen, et al.. (2011). Discovery and evaluation of 3-phenyl-1H-5-pyrazolylamine-based derivatives as potent, selective and efficacious inhibitors of FMS-like tyrosine kinase-3 (FLT3). Bioorganic & Medicinal Chemistry. 19(14). 4173–4182. 14 indexed citations
12.
Greene, Sharon K., Martin Kulldorff, Jie Huang, et al.. (2011). Timely detection of localized excess influenza activity in Northern California across patient care, prescription, and laboratory data. Statistics in Medicine. 30(5). 549–559. 12 indexed citations
13.
Bardach, Naomi S., Jie Huang, Richard Brand, & John Hsu. (2009). Evolving health information technology and the timely availability of visit diagnoses from ambulatory visits: A natural experiment in an integrated delivery system. BMC Medical Informatics and Decision Making. 9(1). 35–35. 13 indexed citations
14.
Fung, Vicki, et al.. (2008). Office Visit Copayments. Medical Care. 46(4). 403–409. 15 indexed citations
15.
Fung, Vicki, Ira B. Tager, Richard Brand, Joseph P. Newhouse, & John Hsu. (2008). The impact of generic-only drug benefits on patients' use of inhaled corticosteroids in a Medicare population with asthma. BMC Health Services Research. 8(1). 151–151. 8 indexed citations
16.
Tseng, Ching‐Ping, Jinn‐Moon Yang, Yen‐Fu Chen, et al.. (2008). Aurintricarboxylic acid inhibits influenza virus neuraminidase. Antiviral Research. 81(2). 123–131. 91 indexed citations
17.
Lafata, Jennifer Elston, Marc J. Gunter, John Hsu, et al.. (2007). Academic Detailing to Improve Laboratory Testing Among Outpatient Medication Users. Medical Care. 45(10). 966–972. 12 indexed citations
18.
Frankel, Richard M., Sue Hee Sung, & John Hsu. (2005). Patients, Doctors, and Videotape: A Prescription for Creating Optimal Healing Environments?. The Journal of Alternative and Complementary Medicine. 11(supplement 1). s–31. 20 indexed citations
19.
Lee, Jin‐Ching, et al.. (2005). High-Throughput Cell-Based Screening for Hepatitis C Virus NS3/4A Protease Inhibitors. Assay and Drug Development Technologies. 3(4). 385–392. 12 indexed citations
20.
Hsu, John, Mary Reed, Richard Brand, et al.. (2004). Cost-Sharing. Medical Care. 42(3). 290–296. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tsegahun Manyazewal Breakdown of academic impact, for papers by Jennifer Williams Breakdown of academic impact, for papers by Jon E. Rohde Breakdown of academic impact, for papers by Leena Gupta Breakdown of academic impact, for papers by Bin Zou Breakdown of academic impact, for papers by Mohan Nadkarni Breakdown of academic impact, for papers by George E. Wright Breakdown of academic impact, for papers by Bernhards Ogutu Breakdown of academic impact, for papers by Sherri O. Stuver Breakdown of academic impact, for papers by Malcolm A Moore
Rankless by CCL
2026